 |
Previous Article | Next Article 
The Journal of Neuroscience, September 1, 2002, 22(17):7737-7745
Phosphorylation of Extracellular Signal-Regulated Kinase in
Primary Afferent Neurons by Noxious Stimuli and Its Involvement in
Peripheral Sensitization
Yi
Dai1,
Koichi
Iwata2,
Tetsuo
Fukuoka1,
Eiji
Kondo3,
Atsushi
Tokunaga1,
Hiroki
Yamanaka1,
Toshiya
Tachibana1,
Yi
Liu1, and
Koichi
Noguchi1
1 Department of Anatomy and Neuroscience, Hyogo College
of Medicine, Hyogo 663-8501, Japan, 2 Department of
Physiology, Nihon University, School of Dentistry, Tokyo 101-8310, Japan, and 3 Institute for Dental Science, Matsumoto Dental
University, Nagano 399-0781, Japan
 |
ABSTRACT |
Alteration in the intracellular signal transduction pathway in
primary afferent neurons may contribute to pain hypersensitivity. We
demonstrated that very rapid phosphorylation of extracellular signal-regulated protein kinases (pERK) occurred in DRG neurons that
were taking part in the transmission of various noxious signals. The
electrical stimulation of A fibers induced pERK primarily in neurons
with myelinated fibers. c-Fiber activation by capsaicin injection
induced pERK in small neurons with unmyelinated fibers containing
vanilloid receptor-1 (VR-1), suggesting that pERK labeling in DRG
neurons is modality specific. Electrical stimulation at the c-fiber
level with different intensities and frequencies revealed that
phosphorylation of ERK is dependent on the frequency. We examined the
pERK in the DRG after application of natural noxious stimuli and found
a stimulus intensity-dependent increase in labeled cell size and in the
number of activated neurons in the c- and A -fiber population.
Immunohistochemical double labeling with phosphorylated ERK/VR-1 and
pharmacological study demonstrated that noxious heat stimulation
induced pERK in primary afferents in a VR-1-dependent manner. Capsaicin
injection into the skin also increased pERK labeling significantly in
peripheral fibers and terminals in the skin, which was prevented by a
mitogen-activated protein kinase/ERK kinase inhibitor,
1,4-diamino-2,3-dicyano-1,4-bis(2-aminopheylthio)butadiene (U0126). Behavioral experiments showed that U0126
dose-dependently attenuated thermal hyperalgesia after capsaicin
injection and suggested that the activation of ERK pathways in primary
afferent neurons is involved in the sensitization of primary afferent
neurons. Thus, pERK in primary afferents by noxious stimulation
in vivo showed distinct characteristics of expression
and may be correlated with the functional activity of primary afferent neurons.
Key words:
extracellular signal-regulated kinase; phosphorylation; dorsal root ganglion; pain stimuli; MAP kinase; peripheral
sensitization
 |
INTRODUCTION |
Primary sensory neurons are highly
specialized to transduce and transmit sensory information from the
periphery to the CNS and are selectively equipped to detect different
kinds of stimuli (Snider and McMahon, 1998 ). The initial step in pain
perception is that noxious thermal, mechanical, or chemical stimuli
excite specialized nociceptive transducer receptor/ion channel
complexes in peripheral terminals of nociceptors. Vanilloid receptor-1
(VR-1), one of the transducer proteins, can generate depolarizing
currents in response to noxious thermal stimuli (Caterina et al., 1997 ; Tominaga et al., 1998 ). VR-1 is a nociceptor-specific cation channel that is the molecular target of capsaicin and is essential for selective modalities of pain sensation and for tissue injury-induced thermal hyperalgesia. Action potentials that are transmitted from the
periphery may activate the intracellular signaling pathway and regulate
gene expression in dorsal root ganglion (DRG) neurons (Fields et al.,
1997 ; Fields, 1998 ). The alteration in gene expression and the
resultant changes in the excitability of DRG neurons may be involved in
peripheral and central sensitization in acute and chronic pain
conditions (Dubner and Ruda, 1992 ; Woolf and Salter, 2000 ).
Much attention has focused on the signal transduction mechanisms of
primary afferent neurons responsible for the modulation of pain
transmission. Recent articles reported that inflammatory mediators,
such as prostaglandin E2, serotonin, epinephrine,
and nerve growth factor, produce hyperalgesia through activation of protein kinase A (PKA), protein kinase C (PKC), or extracellular signal-regulated kinases (ERKs) in the primary afferent neurons (Gold
et al., 1998 ; Khasar et al., 1999 ; Aley et al., 2001 ). ERKs are
mitogen-activated protein kinases (MAPKs) that are activated by
membrane depolarization and calcium influx (Rosen et al., 1994 ), activated by an upstream kinase, MAPK/ERK kinase (MEK) (Chang and
Karin, 2001 ), and known to be one of the intracellular signaling pathways involved in neuronal plasticity (Fields et al., 1997 ; Martin
et al., 1997 ; Fields, 1998 ; Impey et al., 1999 ). Physiological and
pathological activity-dependent activation of ERK occurs in the CNS
(Baraban et al., 1993 ; English and Sweatt, 1996 ; Atkins et al., 1998 ;
Obrietan et al., 1998 ). However, there have been few studies of signal
transduction involved in the activity-dependent plasticity of primary
afferent neurons (Fields et al., 1997 ; Fitzgerald, 2000 ).
Here, we report modality-specific and intensity-dependent ERK
phosphorylation in primary afferent neurons by pain stimuli, an event
that may be involved in peripheral sensitization.
 |
MATERIALS AND METHODS |
Stimulation. Adult male Sprague Dawley rats (220-250
gm) were used. All procedures were performed under sodium pentobarbital anesthesia (50 mg/kg, i.p.). Capsaicin
(8-methyl-N-vanillyl-6-noneamide; Sigma, St. Louis, MO) (10 mM) was dissolved in 10% Tween 80 and injected
into the plantar surface of the left hindpaw (5-200 µl). A brief
force (~47.0N/cm2 for the low intensity
of pinch, 94.1N/cm2 for the high intensity
of pinch) was applied (six times in 10 sec; interval of 10 sec; total
of 2 min) to the plantar surface of the middle of the left hindpaw with
a surgical bulldog clamp. Thermal (42-60°C) stimuli were produced by
immersion of the hindpaw into a water bath (six times in 10 sec;
interval of 10 sec; total of 2 min).
Electrophysiological recordings and stimulations.
Electrophysiological recordings were applied to distinguish the kinds
of nerve fiber that were stimulated. Procedures were performed
initially under anesthesia with pentobarbital sodium (50 mg/kg, i.p.),
followed by maintenance with halothane (2-3%) and air. Rats were
immobilized with pancuronium bromide (1 mg · kg 1 · hr 1,
i.v.) for compound action potential recording. The left sciatic nerve
was exposed and completely isolated from the surrounding connective
tissue. Bipolar platinum wire electrodes were placed under the isolated
sciatic nerve just distal to the level of the joint of the three
terminal branches (the sural, common peroneal, and tibial nerves).
Paraffin oil was pooled, and recording electrodes were placed 25 mm
proximal to the stimulation electrodes. To see c-fiber responses, the
recordings of 100 trials were averaged. On the basis of the data from
these recordings, electrical stimulation was used for activation of
each type of nerve fiber. A train of 60 pulses of 0.1 mA, 0.2 msec, and
100 Hz for A fibers; 0.3 mA, 0.2 msec, and 100 Hz for A fibers; and
1-5 mA, 2 msec, and 0.5-100 Hz for c-fiber stimulation was delivered.
Sham operations without electrical stimulation were also performed. The
electrical stimulations were done 20 min after the incision of skin in
the lower leg.
Immunohistochemistry. After appropriate survival times (the
survival time after stimulation in all experiments was 2 min, except in
the time course study), rats were perfused transcardially with 1%
paraformaldehyde in 0.1 M phosphate buffer
followed by 4% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4. The lumbar (L) 4/5 DRGs or the skin
~0.6 × 0.6 cm2 around the
injection point were removed and processed for phosphorylated ERK
(pERK) immunohistochemistry according to our previous studies (Noguchi
et al., 1995 ; Fukuoka et al., 2001 ). The polyclonal primary antibody
for pERK (New England BioLabs, Beverly, MA) at 1:1000 was used for DAB
staining. For double immunofluorescent staining, the tyramide signal
amplification (TSA; NEN, Boston, MA) fluorescence procedures (Michael
et al., 1997 ) were used for pERK (1:10,000) staining. Subsequently, the
pERK antibody was combined with one of the following antibodies:
monoclonal anti-neurofilament 200 (NF200, 1:400; Sigma), rabbit
polyclonal protein gene product 9.5 (PGP 9.5) antibody (1:1000; Ultra
Clone Ltd., Isle of Wight, UK), or rabbit polyclonal VR-1
antibody (1:1000, gift from Dr. M. Tominaga, Mie University, Mie,
Japan). The characteristics and staining specificity of these
antibodies have been reported previously (Trojanowski et al., 1986 ; Day
and Thompson, 1987 ; Tominaga et al., 1998 ). When two primary antisera
raised in rabbits were combined, nonspecific double labeling was not
observed. A similar protocol has been used by many other workers
(Hunyady et al., 1996 ; Shindler and Roth, 1996 ; Michael et al., 1997 ;
Bennett et al., 1998 ; Amaya et al., 2000 ), and the lack of
cross-reactivity is thought to be attributable to the fact that the TSA
procedure allows the first series primary antibody to be used at a
dilution that is too high to be detected by the second reagent set
(Michael et al., 1997 ). Our data support this explanation. In control
single labeling using indirect labeled immunofluorescence, we were
unable to visualize the pERK antiserum at the dilutions used for the TSA procedure.
Quantitative and statistical analysis for
immunohistochemistry. For DRG neuron quantification, 8-12
sections of the L4/5 DRG were selected randomly from each rat. The
total number and the number of labeled neurons per section were counted
to determine changes in pERK expression in the L4/5 DRG after various
stimuli. The proportion of pERK-expressing DRG neurons was determined
by counting the neuronal profiles that showed distinctive pERK labeling compared with background labeling in DRG sections. The total number of
DRG neurons was obtained by the background staining of neurons and the
Nomarski differential interference contrast image. An average number of
labeled neurons per total neurons was obtained for each animal across
the different tissue sections; then the mean ± SEM across animals
was determined. The cross-sectional area of pERK-labeled neuron
profiles was quantified using a computerized image analysis system (NIH
Image, version 1.62; W. Rasband, National Institutes of Health,
Bethesda, MD). Because a stereological approach was not used in this
study, quantification of the data may represent a biased estimate of
the actual number of neurons. For the quantification in the skin, 8-12
sections of skin were selected randomly in each rat, and the relative
immunostained area of labeled fiber profiles in a outlined profile
(50.25 × 428.81 µm2) crossing the
epidermis and dermis per section was quantified using the computerized
image analysis system (NIH Image, version 1.62). An assistant who was
unaware of the treatment group of the tissue sections performed all
counting. A significance of difference was analyzed using a
t test or ANOVA followed by Fisher's PLSD test.
Western blot analysis. To examine the specificity of the
pERK antibody, Western blot analysis for rat DRG neurons was performed. Animals were deeply anesthetized with diethyl ether and killed by
decapitation. The L4/5 DRG was rapidly removed and lysed with 20 mM Tris-HCl buffer, pH 8.0, containing 1% NP-40,
150 mM NaCl, 1 mM EDTA,
10% glycerol, 0.1% -mercaptoethanol, 0.5 mM
dithiothreitol, and a mixture of proteinase inhibitors. Briefly, the
samples were homogenized in 0.2 ml of lysis buffer reagent and
centrifuged at 4°C. The supernatant, containing 15 µg of protein,
was electrophoresed in a 10-20 SDS-polyacrylamide gel (Bio-Rad,
Hercules, CA) and blotted onto Hybond P membrane (Amersham Biosciences,
Arlington Heights, IL) using Multiphore II (Amersham
Biosciences, Uppsala, Sweden) for 30 min. The blotted membrane was
incubated first with the antibody rabbit anti-phospho-ERK (1:1000; New
England BioLabs) overnight at 4°C. The membrane was then
incubated with the alkaline phosphatase-conjugated second antibody
(goat anti-rabbit IgG; Jackson ImmunoResearch, West Grove, PA) for 2 hr
at room temperature. The membrane was rinsed and treated with nitroblue
tetrazolium (Sigma) and 5-bromo-4-chloro-3-indolyl phosphate (Sigma) to
visualize protein bands.
Behavioral studies. All tests were performed on male rats
weighing 220-250 gm. The MEK inhibitor
1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (U0126;
Calbiochem, Darmstadt, Germany) (diluted in 2.5% DMSO; dose
7.5, 0.75, and 0.075 µg in 10 µl per paw) was first injected intradermally into the middle of the hindpaw using a 10 µl
microsyringe (Hamilton, Reno, NV); 2 min later, capsaicin (15 µg in 5 µl per paw) was injected by the same procedure. Primary thermal
hyperalgesia to the capsaicin injection site was measured using the
Hargreaves method (Hargreaves et al., 1988 ) before and 10, 30, 60, and
120 min after injection. The heat stimulus was terminated with a
withdrawal response or at 20 sec to avoid skin damage. Two latencies
were recorded and averaged for the ipsilateral hindpaw in each test session. Secondary mechanical allodynia was assessed with calibrated von Frey filaments using an up-down paradigm (Chaplan et al., 1994 ).
Briefly, animals were placed in plastic cages with a wire mesh floor
and allowed to acclimate for 15 min before each test session. To
determine the 50% response threshold, the von Frey filaments were
applied to the uninjured area surrounding the capsaicin injection site
for 8 sec or until a withdrawal response occurred. Testing was
initiated with the 4.0 gm intensity of filament, and the cutoffs of 0.6 gm and 26 gm intensities of filament were selected as the lower and
upper limits for testing, respectively. When a positive response
was noted, we tested a weaker stimulus. If there was no response to a
stimulus, then a stronger stimulus was presented. After the initial
threshold crossing, this procedure was repeated for five stimulus
presentations per animal per test session. An assistant who was unaware
of the treatment group performed all of the behavioral experiments.
 |
RESULTS |
To clarify the in vivo activation of ERK in DRG
neurons, we stimulated the receptive fields in a variety of ways and
used an antibody that recognizes pERK. We found very few neurons
labeled for pERK in the naive DRG (Fig.
1A). However we found
that selective stimulation of c fibers by capsaicin injection into the
plantar surface of the hindpaw induced a number of small DRG neurons
labeled for pERK (Fig. 1B). To confirm the
specificity of the antibody, we used Western blotting with the pERK
antibody (Fig. 1B, inset) and found that
this antibody could recognize two bands (p42/44 ERK) (n = 3), which is consistent with previous reports (Fields et al., 1997 ;
Impey et al., 1998 ). We examined the time course of phosphorylation of
ERK in small DRG neurons after capsaicin injection and found that this
response was very quick: the peak was 2 min after stimulation and the
number of labeled cells rapidly declined for 10 min (Fig.
1C). The pERK-labeled small neurons were not labeled for
NF200 (Trojanowski et al., 1986 ), a marker of neurons with myelinated
fibers, indicating that these neurons had unmyelinated fibers (Fig.
1D). The double-labeling experiment with pERK and
VR-1, which is a capsaicin receptor, showed that 91.7 ± 2.1%
(mean ± SEM; n = 4) of pERK-labeled cells were
also labeled for VR-1 after activation of c fibers by capsaicin
injection into the plantar surface of the hindpaw (Fig.
1E). The topical application of lidocaine (1%)
around the sciatic nerve significantly prevented pERK labeling in small
DRG neurons 2 min after capsaicin injection (n = 4)
(Fig. 1F,G).

View larger version (97K):
[in this window]
[in a new window]
|
Figure 1.
Stimulus-evoked ERK phosphorylation in rat DRG
neurons. A, L4 DRG section (30 µm) immunostained for
pERK in the naive rat. B, pERK labeling in many small L4
DRG neurons 2 min after intraplantar injection of capsaicin (10 mM, 200 µl). The inset shows a Western
blot of capsaicin-stimulated DRG tissue with pERK antibody.
C, Time course of capsaicin-evoked pERK expression in
L4/5 DRG neurons (n = 5 at each time point;
*p < 0.01; **p < 0.001 compared with naive). D, L4 DRG section
double-immunostained for NF200 (red) and pERK
(green) after intraplantar capsaicin injection.
E, Colocalization of pERK (green)
and VR-1 (red) in L4 DRG neurons after capsaicin
injection. Double staining appears yellow. F,
G, Capsaicin-induced pERK was inhibited by the lidocaine block
to the sciatic nerve. Cap, Capsaicin group;
Lid, capsaicin plus lidocaine group
(**p < 0.001 compared with capsaicin group).
H, Example of 0.1 mA (a) and 0.3 mA (b, c) evoked action potentials at the sciatic nerve.
a, A response; b, c, A and A
responses with no c response (c; 100 sweeps were
averaged). I, L4 DRG section immunostained for pERK 2 min after 0.3 mA of stimulation to the sciatic nerve. J,
L4 DRG section immunostained for NF200 (a marker of myelinated neurons,
red) and pERK (green) after a 0.3 mA electrical stimulation. Double staining appears
yellow. Scale bars, 100 µm.
|
|
Subsequently, we examined the pERK labeling in DRG neurons after
A-fiber stimulation. We used 0.1 mA of electrical stimulation to the
sciatic nerve and found that this A stimulation (no A response)
(Fig. 1H,a) induced very few neurons labeled for pERK in the DRG (data not shown). The sham operation induced no pERK labeling in the DRG. We then used 0.3 mA of stimulation and found that
this stimulation produced A -fiber activation and no c-fiber activation (Fig. 1H,b,c). The electrical stimulation
at the A -fiber level induced labeling for pERK in some
medium-to-large DRG neurons (Fig. 1I). Double
labeling with pERK and NF200 showed that 90.9 ± 2.9% (mean ± SEM; n = 4) of pERK-labeled neurons contained NF200 (Fig. 1J), which was in clear contrast to the effects
of c-fiber stimulation (Fig. 1B,D). These data
indicated that the electrical stimulation of A fibers induced pERK,
primarily in neurons with myelinated fibers. Thus, these data clearly
indicate that the action potentials in c and A fibers of primary
afferents could rapidly induce an activation of the MAPK cascade in
individual neurons. These findings demonstrate that the modality of
stimulation was highly correlated with the expression pattern of pERK
in DRG neurons.
We examined the changes in pERK labeling after different frequencies
and intensities of c-fiber electrical stimulation. First, we found that
c-fiber stimulation at 0.5 Hz, 3 mA, and 2 msec to the sciatic
nerve induced pERK labeling in small DRG neurons (Fig.
2A). When the frequency
of electrical stimulation increased (10 Hz, 3 mA, and 2 msec), the
number of pERK-labeled DRG neurons was clearly increased (Fig.
2B). The total number of pERK-labeled neurons after
c-fiber stimulation at 10 Hz was significantly increased compared with
the 0.5 Hz stimulation (Fig. 2E). However, a greater frequency of stimulation (100 Hz) induced less pERK labeling (Fig. 2C,E). We measured the cross-sectional areas of neurons
labeled for pERK after electrical stimulation at different frequencies (Fig. 2D). Each size-distribution curve after
different frequencies had a peak of ~500
µm2, and the pERK labeling after higher
frequencies (50 and 100 Hz) increased the number of medium- to
large-sized neurons (>1000 µm2). We
also examined the different intensities of c-fiber electrical stimulation. Three intensities (1, 3, and 5 mA) to the sciatic nerve
showed no significant difference in the size distribution and the total
number of pERK-labeled neurons (Fig. 2F,G). The 1, 3, and 5 mA electrical stimulations to the sciatic nerve activate both A
and C fibers (Fig. 2H). These data suggested that the
pERK labeling after electrical stimulation to the sciatic nerve is partly dependent on the frequency of the stimulation.

View larger version (86K):
[in this window]
[in a new window]
|
Figure 2.
Electrical stimulation-induced pERK expression.
A-C, Photomicrographs of pERK-labeled neurons in L4 DRG
2 min after 60 pulses of 3 mA/0.5 Hz (A), 3 mA/10
Hz (B), and 3 mA/100 Hz (C)
electrical stimulation to the sciatic nerve. D,
Size distribution of pERK-labeled neurons in the L4/5 DRGs in the rats
that received 60 pulses of 3 mA/0.5 Hz, 3 mA/10 Hz, 3 mA/50 Hz, and 3 mA/100 Hz (n = 3 for each frequency) electrical
stimulation to the sciatic nerve. E, The
percentage of pERK-labeled neurons in L4/5 DRG neurons
(n = 3 for each frequency; ANOVA test shows a
p < 0.05 significant change among the groups;
*p < 0.01 compared with the 0.5 Hz group by
Fisher's PLSD test). F, Size distribution of
pERK-labeled neurons in the L4/5 DRGs in the rats that received 60 pulses of 1 mA/0.5 Hz, 3 mA/0.5 Hz, and 5 mA/0.5 Hz
(n = 3 for each intensity) electrical stimulation
to the sciatic nerve. G, The percentage of
pERK-labeled neurons in L4/5 DRG neurons (n = 3 for
each intensity; no significant change by ANOVA). H,
Electrical stimulation (3 mA) to the sciatic nerve showed both A- and
C-fiber responses (100 sweeps were averaged). Scale bars, 100 µm.
|
|
Subsequently, we examined the pERK labeling after natural stimulation.
We first examined the relationship between thermal stimuli at different
temperatures and the induction of pERK in DRG neurons. We applied
thermal stimuli by immersion of the hindpaw into warm to hot water
(42-60°C). The thermal stimulus of 42°C induced pERK only in very
small cells (Fig. 3A). To
determine whether the very small cells labeled for pERK at 42°C were
neurons, double labeling was performed with pERK and PGP 9.5 (Day and
Thompson, 1987 ), which is a neuronal marker. All pERK-labeled cells
were also labeled for PGP 9.5 (Fig. 3B), indicating that the
innocuous warm stimulus of 42°C activates a subpopulation of DRG
neurons with very small cell bodies. In contrast, noxious heat
stimulation at higher temperatures was found to induce pERK in more and
larger neurons (Fig. 3C). The double-labeling experiment
revealed that some labeled neurons at 60°C showed colocalization with
NF200 (Fig. 3D), indicating the activation of neurons with A
fibers at higher temperatures. The size distribution of pERK-labeled neurons at graded stimulus temperatures shows a clear rightward shift
of the distribution curve (Fig. 3E) and an increased number of labeled neurons (Fig. 3F). The mean areas of
pERK-labeled neurons at 50, 54, and 60°C were significantly increased
compared with that at 42°C (p < 0.05; one-way
ANOVA).

View larger version (57K):
[in this window]
[in a new window]
|
Figure 3.
Thermal stimulus intensity-dependent pERK
expression. A, pERK labeling in L4 DRG neurons 2 min
after thermal stimulation at 42°C. B, Colocalization
of pERK (green) and PGP 9.5 (red)
in L4 DRG neurons after the 42°C stimulus. Double staining appears
yellow. C, pERK labeling in L4 DRG
neurons 2 min after thermal stimulation at 60°C. D,
Colocalization of pERK (green) and NF200
(red) in L4 DRG neurons after the 60°C stimulus.
Double staining appears yellow. E, Size
distribution of pERK-labeled neurons in the L4/5 DRGs 2 min after
thermal stimulation at 42, 46, 50, 54, and 60°C. F,
The percentage of pERK-labeled neurons in L4/5 DRG neurons
(n = 5 for each temperature; *p < 0.01; **p < 0.001 compared with 38°C). Scale
bars, 100 µm.
|
|
We also examined pERK labeling after mechanical stimulation of the
peripheral tissue. We applied high and low intensities of pinch
stimulation to the plantar surface of the hindpaw (Fig. 4A,B). The
high-intensity pinch, in contrast to the low-intensity pinch, produced
a greater number of DRG neurons that were labeled for pERK, and these
neurons tended to be larger. These tendencies were clearly apparent in
the size distribution of pERK neurons (Fig. 4C):
low-intensity pinch induced pERK almost exclusively in very small
neurons (mean, 392.9 ± 37.7 µm2;
n = 5), whereas high-intensity stimulation induced pERK
in larger-sized neurons, remarkably in 400-700
µm2 neurons (mean, 495.1 ± 74.2 µm2; n = 5). The change
in mean size of pERK-labeled neurons was statistically significant
(p < 0.05). The total number of pERK-labeled neurons after high-intensity stimulation was significantly increased compared with that after low-intensity stimulation (Fig.
4D). The innocuous tactile stimulation of brushing
the rat hindpaw did not induce pERK in DRG neurons (data not shown).
These data from Figures 3 and 4 suggest that the increase in thermal
and mechanical stimulus intensity was highly correlated with the number and size of DRG neurons in which the ERK cascade was activated.

View larger version (85K):
[in this window]
[in a new window]
|
Figure 4.
Mechanical stimulus intensity-dependent pERK
expression. A, B, Photomicrographs of pERK-labeled
neurons in L4 DRG 2 min after low-intensity
(A) and high-intensity
(B) mechanical stimulation of the plantar surface
of the hindpaw. Scale bars, 100 µm. C, Size-frequency
histogram illustrating the distribution of the profiles 2 min after
low-intensity (white) and high-intensity
(black) mechanical stimulation. D, The
percentage of labeled neurons in L4/5 DRG neurons
(n = 5 for each intensity; **p < 0.001).
|
|
These characteristics of pERK labeling in primary afferent neurons
suggest that phosphorylation of ERK may reflect the activation of
primary afferent neurons. Therefore, we subsequently examined the
relationship between the VR-1 and thermal-mechanical stimulation using
pERK labeling. We found that many neurons were double labeled for VR-1
and pERK after noxious heat stimulation (Fig.
5A), and that the percentage
of VR-1-labeled neurons with pERK labeling increased with stimulus
temperature (Fig. 5B). In contrast, 75-80% of pERK-labeled
neurons were also labeled for VR-1 (Fig. 5C) at all stimulus
temperatures (42-60°C). To ascertain whether ERK activation in
neurons by different stimuli is specifically mediated through this
VR-1, we used the competitive VR-1 antagonist capsazepine (Bevan et
al., 1992 ) to block VR-1 activation in primary afferent fibers after
natural stimulation, such as heat or mechanical stimulation. The pERK
labeling in DRG neurons after capsaicin injection into the hindpaw was
dose-dependently inhibited by topical injection of capsazepine (0.1-10
mM, 100 µl) given 2 min before capsaicin (10 mM, 50 µl) injection (Fig. 5D). The
increase in pERK-labeled neurons produced by 54°C stimulation of the
hindpaw was also dose-dependently suppressed by the capsazepine
pretreatment (Fig. 5E). However, the mechanical
stimulation-induced pERK in DRG neurons was not affected by this
treatment (Fig. 5F). These data clearly demonstrate that noxious heat stimulation but not mechanical stimulation induced ERK phosphorylation of DRG neurons through VR-1 and are consistent with
the behavioral data from VR-1 knock-out mice (Caterina et al., 2000 ;
Davis et al., 2000 ).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 5.
Thermal stimulus-specific phosphorylation of ERK
in DRG neurons with VR-1. A, Colocalization of pERK
(green) and VR-1 (red) in L4 DRG
neurons after thermal stimulation (54°C) of the plantar surface of
the hindpaw. Double staining appears yellow.
B, Percentages of VR-1-labeled neurons also labeled for
pERK after different thermal stimuli (**p < 0.001 compared with 38°C). C, Percentage of pERK-labeled
neurons also labeled for VR-1 after different thermal stimuli
(n = 4 at each temperature). D-F,
Percentage of VR-1-labeled neurons in L4/5 DRG neurons after
capsazepine treatment combined with capsaicin injection
(D), thermal stimulation (54°C)
(E), or mechanical stimulation
(F) of the plantar surface of the hindpaw
(n = 5 for each group; *p < 0.05; **p < 0.001 compared with vehicle). All data
show pERK expression 2 min after stimulation. Veh,
Vehicle. Scale bar, 100 µm.
|
|
To determine the functional roles of phosphorylation of ERK in primary
afferents in peripheral tissues, we examined the changes in pERK in
skin and pain behaviors after capsaicin injection into the plantar
surface of the hindpaw. First, we examined pERK immunoreactivity in
primary afferent terminals in the skin of the plantar surface of the
hindpaw. In the skin of control rats, the pERK-labeled fibers and
terminals were scattered in the dermis and epidermis (Fig.
6A). At 2 min after
capsaicin injection (5 µl, 10 mM), the pERK-labeled nerve bundles in the dermis and terminals penetrating into
the epidermis were clearly increased compared with controls (Fig.
6B). To ascertain whether the pERK labeling was on
the nerve terminals, we used double labeling with PGP 9.5 and found
that most pERK labeling in the dermis and epidermis was also labeled for PGP 9.5 (Fig. 6C). This dose of capsaicin induced pERK
in very few DRG cell bodies. Pretreatment with a selective MEK
inhibitor, U0126, 2 min before capsaicin injection clearly prevented
the increase in the pERK immunoreactivity in the skin (Fig.
6D). Quantification of pERK-labeled fibers and
terminals in the dermis and epidermis revealed that pretreatment with
the MEK inhibitor U0126 before capsaicin injection significantly
suppressed the increase in pERK by capsaicin injection (Fig.
6E). These data indicate that activation of the ERK
signal transduction pathway occurred in the nerve terminals and fibers
in the skin, as well as cell bodies in the DRG, in response to
stimulation of the receptor in the periphery.

View larger version (42K):
[in this window]
[in a new window]
|
Figure 6.
ERK phosphorylation in peripheral nerve terminals
and fibers and behavioral effects after capsaicin injection.
A-D, Immunostaining of pERK labeling of the plantar
surface of the hindpaw. A, Control rats showed the
pERK-labeled nerve bundle in the dermis and weak labeling in nerve
terminals that penetrate into the epidermis. B,
Increased labeling of pERK in nerve terminals and fibers was observed
in rats 2 min after capsaicin injection (5 µl, 10 mM)
into the plantar surface of the hindpaw. C,
Colocalization of pERK (green) and PGP 9.5 (red) in the plantar surface of the rat's hindpaw 2 min
after capsaicin injection. Double staining appears
yellow. D, U0126 injection 2 min before
capsaicin injection prevented the increase in pERK labeling in
peripheral nerve terminals and fibers. E, Relative
immunostaining analysis of pERK in the nerve of plantar skin tissue.
Each bar represents the relative pERK immunostaining
area in the skin tissue. veh, Vehicle;
cap, capsaicin. n = 5 for each group
(*p < 0.05 compared with veh+cap).
F, G, Behavioral changes after the injection of
capsaicin and the MEK inhibitor U0126 into the plantar surface of the
hindpaw. F, Thermal hyperalgesia was examined using the
plantar test. U0126 injections (7.5 and 0.75 µg) significantly
changed the time course of withdrawal latency to noxious heat after
capsaicin injection into the plantar surface of the hindpaw
(n = 6 for each group; *p < 0.05; **p < 0.001). G, Mechanical
allodynia was examined using von Frey filaments. U0126 did not show any
effect on the 50% threshold of response to mechanical stimuli into the
plantar surface of the hindpaw (n = 6 each group).
Scale bars, 100 µm.
|
|
We subsequently examined whether the phosphorylation of ERK contributes
to capsaicin-induced thermal hyperalgesia and secondary mechanical
allodynia. The capsaicin injection induced a rapid thermal hyperalgesia
at the site of injection that recovered almost completely by 2 hr after
injection. The MEK inhibitor U0126 dose-dependently inhibited thermal
hyperalgesia (Fig. 6F). The time courses of withdrawal latency with 7.5 and 0.75 µg of U0126-treated rats were
significantly different from those of vehicle-treated rats (p < 0.001; two-way repeated ANOVA). U0126 did
not affect the withdrawal latencies in naive rats that received no
capsaicin treatment (data not shown). In contrast to the effect of
U0126 against the thermal hyperalgesia, there was no effect of U0126 on
secondary mechanical allodynia (Fig. 6G). These behavioral data indicate that the phosphorylation of ERK through MEK activity in
primary afferent neurons is involved in the formation of thermal hyperalgesia (i.e., sensitization of primary afferent neurons).
 |
DISCUSSION |
In this article, we show the activity-dependent phosphorylation of
ERK in primary afferent neurons. Activity-dependent activation of ERK
has been reported in the CNS, especially in the hippocampus (Baraban et
al., 1993 ; English and Sweatt, 1996 ; Atkins et al., 1998 ; Durek and
Fields, 2001 ). Recently, several studies have reported ERK
phosphorylation in the nociceptive pathway; for example, nociceptive
stimuli induce ERK phosphorylation in the spinal dorsal horn (Ji et
al., 1999 , 2002 ; Karim et al., 2001 ), and this event may be related to
the hypersensitivity of spinal neurons in inflammatory pain. The
activation of metabotropic glutamate receptors in dorsal horn neurons
by peripheral inflammation is shown to activate a downstream ERK
pathway and result in enhanced pain sensitivity. With respect to the
primary afferent neurons, it has been shown that the ERK cascade acts
in epinephrine-induced hyperalgesia: the Ras-MEK-ERK1/2 pathway is
activated independently of PKA or PKC (Aley et al., 2001 ). Nerve
growth factor injected into the peripheral tissue increased pERK
labeling in tyrosine kinase A-containing DRG neurons (Averill et
al., 2001 ). However, there has been no study examining the ERK
activation after application of noxious stimuli to normal tissue.
Action potentials that are transmitted from the periphery and
associated Ca2+ transients could activate
the specific intracellular signaling pathway and regulate gene
expression in DRG neurons (Fields et al., 1997 ; Fields, 1998 ). The
inhibition of capsaicin-induced pERK labeling by lidocaine block in the
present study demonstrates a role of action potentials in the pERK
activation. An in vitro study of mouse DRG neurons showed
that the phosphorylation of cAMP-responsive element binding protein and
ERK/MAP kinase was increased by action potentials with specific
temporal patterns (Fields et al., 1997 ). Other studies suggest that
activation of the MAPK (ERK) pathway modulates the voltage-dependent
calcium channel (Fitzgerald and Dolphin, 1997 ; Fitzgerald, 2000 ), which is in turn involved in the activity of sensory neurons.
A -level electrical stimulation induced pERK in large neurons with
NF200. In contrast, c-fiber stimulation by capsaicin injection induced
pERK in small neurons containing VR-1 (Fig.
1B,I). These data indicated that action
potentials transmitted through the primary afferent neurons by stimuli
to the periphery induced pERK in DRG cell bodies in a modality-specific
way. We found that the electrical stimulation-induced phosphorylation
of ERK was dependent on the frequency of stimulation. The frequency may
be more effective for inducing pERK in DRG neurons compared with the
intensity of the electrical stimulation at the c-fiber level. Actually,
as natural stimuli, the intensity of the stimulation of the receptive field was transmitted to the CNS as a function of the frequency of the
action potentials evoked by the stimuli (Willis and Coggeshall, 1991 ).
More intense natural stimuli induced more frequent impulses transmitted
by the primary afferents (Raja et al., 1999 ). These characteristics of
the primary afferents might be relevant to the data in the present
study, in which the 10 Hz electrical stimulation was the most effective
in the induction of pERK in DRG neurons. Higher-frequency stimuli (50 or 100 Hz) showed decreased pERK labeling, because these high
frequencies may result in the failure to induce full generation of
action potentials in the DRG (Djouhri et al., 2001 ).
An interesting finding in the present study is that the natural
stimulation of the receptive field with different intensities resulted
in changes in a subpopulation of pERK-labeled neurons. The increase in
stimulus intensity resulted in a rightward shift of the
size-distribution curve of pERK-labeled neurons (Figs. 3, 4). This
tendency was observed in experiments using both mechanical and thermal
stimuli, and the number of pERK-labeled neurons also increased as
stimulus intensity increased. The percentage of pERK-labeled neurons
after natural noxious stimuli to the receptive field was smaller than
after electrical stimulation at the c-fiber level. The reason for this
discrepancy is that natural stimulation of the receptive field
(mechanical or thermal) may activate a part of the L4/5 DRG neurons
innervating the hindpaw. Most pERK-labeled neurons are presumably
C-polymodal nociceptors. Our data suggest that smaller neurons have
lower thresholds in terms of pERK activation in C-polymodal receptors.
The intense stimuli induced pERK in NF200-containing neurons, probably
in A mechanothermal nociceptors (Fig. 3D). The threshold
of the A mechanothermal nociceptor is higher than that of
C-polymodal nociceptors (LaMotte et al., 1983 ), which is consistent
with our data that higher temperatures induce double labeling with pERK
and NF200.
The characteristics of pERK labeling in DRG neurons after noxious
stimuli clearly indicated that the pERK labeling is correlated with the
activation state of primary afferent neurons. Therefore, we believe
that examination of pERK is very useful as an indicator of the
activated DRG neurons after noxious stimuli in vivo.
Different noxious stimuli, such as capsaicin injection, mechanical
stimuli, and thermal stimuli, induced a variable number of DRG neurons labeled for pERK, suggesting that each noxious stimulus may have a
different threshold for activation of the ERK pathway. In addition, non-noxious stimuli, such as the 42°C stimuli, induced pERK labeling in a small number of small neurons. These data suggest that not only
noxious stimuli but also innocuous stimuli may induce pERK labeling in
DRG neurons. The direct relationship between phosphorylation of ERK and
electrophysiological activity in each neuron was not demonstrated here,
because the histochemical analysis of the DRG tissue used here did not
give us the relationship with electrophysiological activity in
individual neurons. Additional study using single-cell recording and
analysis of phosphorylation of proteins in the DRG neurons may be required.
As a useful application of pERK labeling by natural stimuli, we
examined the relationship between natural stimuli and the function of
VR-1. The double-labeling experiments with pERK and VR-1 after natural
stimuli showed a high double-labeling ratio after thermal stimuli. The
VR-1 antagonist injected into the peripheral tissue just before natural
stimulation inhibited the pERK activation in primary afferent neurons
evoked by thermal stimuli but not mechanical stimuli. These findings
were very consistent with the previous electrophysiological studies and
gene knock-out studies of VR-1 function (Caterina et al., 1997 , 2000 ;
Tominaga et al., 1998 ; Davis et al., 2000 ). The primary afferent
activation through VR-1 by capsaicin injection or thermal stimuli may
produce action potentials, which in turn result in the phosphorylation
of ERK in DRG neurons. The inhibition of heat stimulation-induced pERK labeling by capsazepine was less effective than that of
capsaicin-induced pERK labeling (Fig. 5D,E). One possible
reason for this may be a methodological problem. The receptive fields
that received heat stimuli were larger than the area injected with
capsazepine in this experiment. Another possible explanation is that
unidentified heat receptors, other than the VR-1, may be working to
induce pERK labeling in DRG neurons.
We also found pERK activation in peripheral nerve terminals and fibers
as well as DRG cell bodies (Fig. 6). The inhibition of the MEK
inhibitor of pERK labeling in peripheral terminals revealed that the
signal transduction pathway through MEK and ERK is working in
peripheral nerve terminals after activation of VR-1 by capsaicin
injection with the same time course as DRG cell bodies. Because the
application of the MEK inhibitor prevented thermal hyperalgesia after
capsaicin injection, the dense labeling in the epidermis preparation of
these fibers and the nerve bundle in the dermis suggested nociceptor
activation (i.e., peripheral sensitization). The changes in ERK
phosphorylation in peripheral terminals might affect the sensitivity of
the primary afferent itself and consequently affect the pain behavior.
In a human study, after the injection of capsaicin into the skin,
primary hyperalgesia and secondary hyperalgesia appeared around the
injection site (Torebjork et al., 1992 ). In the present study, the
secondary mechanical allodynia was not changed by application of MEK
inhibitor to the peripheral tissue. Because the secondary mechanical
allodynia is a result of the central sensitization after capsaicin
injection (Raja et al., 1999 ), we believe that the phosphorylation of
ERK in peripheral nerve is not involved in the central sensitization. A
number of recent studies using isolated DRG neurons in culture have
shed light on the cellular and molecular mechanisms of nociception and
sensitization (for review, see Julius and Basbaum, 2001 ). The signaling
pathway mediating hyperalgesia produced by inflammatory agents has been
examined extensively (Gold et al., 1998 ; Khasar et al., 1999 ; Aley et
al., 2001 ; Ji et al., 2002 ). The molecular mechanisms by which some
chemicals, such as bradykinin, modulate VR-1 activity have been
reported to show the involvement of PKC and phospholipase C signaling
pathways (Premkumar and Ahern, 2000 ; Chuang et al., 2001 ). Our data
indicating that the ERK pathway was activated shortly after capsaicin
injection and was involved in the thermal hyperalgesia might account
for the important signaling mechanism of peripheral sensitization.
We demonstrated in vivo that very rapid phosphorylation of
ERK occurred in DRG neurons that were taking part in the transmission of various noxious signals. Moreover, intensity-dependent changes in
subpopulations showing pERK labeling are novel findings that would have
been difficult to obtain using electrophysiological techniques. The
phosphorylation of ERK in DRG neurons after noxious stimulation might
be useful for examining the activation state of each neuron that
contains various pain-related molecules. Moreover, using this pERK
activation, we could confirm the physiological role of the VR-1 in
nociception and found that the ERK signaling pathway plays an important
role in peripheral sensitization after noxious stimulation to the
peripheral tissues.
 |
FOOTNOTES |
Received April 9, 2002; revised June 11, 2002; accepted June 13, 2002.
This study was supported in part by grants-in-aid for Scientific
Research and a grant for the Open Research Center of the Hyogo College
of Medicine from the Japanese Ministry of Education, Science, and
Culture. We thank Dr. Tominaga for providing the VR-1 antibody. We
gratefully acknowledge technical assistance from Kimiko Kobayashi and
Nobumasa Ushio. We thank Dr. D. A. Thomas for correcting the
English usage in this manuscript.
Correspondence should be addressed to Koichi Noguchi, Department of
Anatomy and Neuroscience, Hyogo College of Medicine, 1-1 Mukogawa-cho,
Nishinomiya, Hyogo 663-8501, Japan. E-mail:
noguchi{at}hyo-med.ac.jp.
 |
REFERENCES |
-
Aley KO,
Martin A,
McMahon T,
Mok J,
Levine JD,
Messing RO
(2001)
Nociceptor sensitization by extracellular signal-regulated kinases.
J Neurosci
21:6933-6939[Abstract/Free Full Text].
-
Amaya F,
Decosterd I,
Samad TA,
Plumpton C,
Tate S,
Mannion RJ,
Costigan M,
Woolf CJ
(2000)
Diversity of expression of the sensory neuron-specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2.
Mol Cell Neurosci
15:331-342[Web of Science][Medline].
-
Atkins CM,
Selcher JC,
Petraitis JJ,
Trzaskos JM,
Sweatt JD
(1998)
The MAPK cascade is required for mammalian associative learning.
Nat Neurosci
1:602-609[Web of Science][Medline].
-
Averill S,
Delcroix JD,
Michael GJ,
Tomlinson DR,
Fernyhough P,
Priestley JV
(2001)
Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurons.
Mol Cell Neurosci
18:183-196[Web of Science][Medline].
-
Baraban J,
Fiore RS,
Sanghera JS,
Paddon HB,
Pelech SL
(1993)
Identification of p42 mitogen-activated protein kinase as a tyrosine kinase substrate activated by maximal electroconvulsive shock in hippocampus.
J Neurochem
60:330-336[Web of Science][Medline].
-
Bennett DL,
Michael GJ,
Ramachandran N,
Munson JB,
Averill S,
Yan Q,
McMahon SB,
Priestley JV
(1998)
A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury.
J Neurosci
18:3059-3072[Abstract/Free Full Text].
-
Bevan S,
Hothi S,
Hughes G,
James IF,
Rang HP,
Shah K,
Walpole CS,
Yeats JC
(1992)
Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin.
Br J Pharmacol
107:544-552[Web of Science][Medline].
-
Caterina MJ,
Schumacher MA,
Tominaga M,
Rosen TA,
Levine JD,
Julius D
(1997)
The capsaicin receptor: a heat-activated ion channel in the pain pathway.
Nature
389:816-824[Web of Science][Medline].
-
Caterina MJ,
Leffler A,
Malmberg AB,
Martin WJ,
Trafton J,
Petersen-Zeitz KR,
Koltzenburg M,
Basbaum AI,
Julius D
(2000)
Impaired nociception and pain sensation in mice lacking the capsaicin receptor.
Science
288:306-313[Abstract/Free Full Text].
-
Chang L,
Karin K
(2001)
Mammalian MAP kinase signaling cascades.
Nature
410:37-40[Medline].
-
Chaplan SR,
Bach FW,
Pogrel JW,
Chung JM,
Yaksh TL
(1994)
Quantitative assessment of tactile allodynia in the rat paw.
J Neurosci Methods
53:55-63[Web of Science][Medline].
-
Chuang HH,
Prescott ED,
Kong H,
Shields S,
Jordt SE,
Basbaum AI,
Chao MV,
Julius D
(2001)
Bradykinin and nerve growth factor release the capsaicin receptor from Ptdlns(4,5)P2-mediated inhibition.
Nature
411:957-962[Medline].
-
Davis JB,
Gray J,
Gunthorpe MJ,
Hatcher JP,
Davey PT,
Overend P,
Harries MH,
Latcham J,
Clapham C,
Atkinson K,
Hughes SA,
Rance K,
Grau E,
Harper AJ,
Pugh PL,
Rogers DC,
Bingham S,
Randall A,
Sheardown SA
(2000)
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.
Nature
405:183-187[Medline].
-
Day IN,
Thompson RJ
(1987)
Molecular cloning of cDNA coding for human PGP 9.5 protein: a novel cytoplasmic marker for neurones and neuroendocrine cells.
FEBS Lett
210:157-160[Web of Science][Medline].
-
Djouhri L,
Dawbarn D,
Robertson A,
Newton R
(2001)
Time course and nerve growth factor dependence of inflammation-induced alterations in electrophysiological membrane properties in nociceptive primary afferent neurons.
J Neurosci
15:8722-8733.
-
Dubner R,
Ruda MA
(1992)
Activity-dependent neuronal plasticity following tissue injury and inflammation.
Trends Neurosci
15:96-103[Web of Science][Medline].
-
Durek SM,
Fields RD
(2001)
Mitogen-activated protein kinase/extracellular signal-regulated kinase activation in somatodendritic compartments: roles of action potentials, frequency, and model of calcium entry.
J Neurosci
21:RC122:1-5[Web of Science][Medline].
-
English JD,
Sweatt JD
(1996)
Activation of p42 mitogen-activated protein kinase in hippocampal long-term potentiation.
J Biol Chem
271:24329-24332[Abstract/Free Full Text].
-
Fields RD
(1998)
Effects of ion channel activity on development of dorsal root ganglion neurons.
J Neurobiol
37:158-170[Web of Science][Medline].
-
Fields RD,
Eshete F,
Stevens B,
Itoh K
(1997)
Action potential-dependent regulation of gene expression: temporal specificity in Ca2+, cAMP-responsive element binding proteins, and mitogen-activated protein kinase signaling.
J Neurosci
17:7252-7266[Abstract/Free Full Text].
-
Fitzgerald EM
(2000)
Regulation of voltage-dependent calcium channels in rat sensory neurones involves a Ras-mitogen-activated protein kinase pathway.
J Physiol (Lond)
527:433-444[Abstract/Free Full Text].
-
Fitzgerald EM,
Dolphin AC
(1997)
Regulation of rat neuronal voltage-dependent calcium channels by endogenous p21-ras.
Eur J Neurosci
9:1252-1261[Web of Science][Medline].
-
Fukuoka T,
Kondo E,
Dai Y,
Hashimoto N,
Noguchi K
(2001)
Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model.
J Neurosci
21:4891-4900[Abstract/Free Full Text].
-
Gold MS,
Levine J,
Correa AM
(1998)
Modulation of TTX-R Ina by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro.
J Neurosci
18:10345-10355[Abstract/Free Full Text].
-
Hargreaves K,
Dubner R,
Brown F,
Flores C,
Joris J
(1988)
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.
Pain
32:77-88[Web of Science][Medline].
-
Hunyady B,
Krempels K,
Harta G,
Mezey E
(1996)
Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining.
J Histochem Cytochem
44:1353-1362[Abstract].
-
Impey S,
Obrietan K,
Wong ST,
Poser S,
Yano S,
Wayman G,
Deloulme JC,
Chan G,
Storm DR
(1998)
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation.
Neuron
21:869-883[Web of Science][Medline].
-
Impey S,
Obrietan K,
Storm DR
(1999)
Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity.
Neuron
23:11-14[Web of Science][Medline].
-
Ji RR,
Baba H,
Brenner GJ,
Woolf CJ
(1999)
Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity.
Nat Neurosci
2:1114-1119[Web of Science][Medline].
-
Ji RR,
Befort K,
Brenner GJ,
Woolf CJ
(2002)
ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity.
J Neurosci
22:478-485[Abstract/Free Full Text].
-
Julius D,
Basbaum AI
(2001)
Molecular mechanisms of nociception.
Nature
413:203-210[Medline].
-
Karim F,
Wang CC,
Gereau IV RW
(2001)
Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice.
J Neurosci
21:3771-3779[Abstract/Free Full Text].
-
Khasar SG,
Lin YH,
Martin A,
Dadgar J,
McMahon T,
Wang D,
Hundle B,
Aley KO,
Isenberg W,
McCarter G,
Green PG,
Hodge CW,
Levine JD,
Messing RO
(1999)
A novel nociceptor signaling pathway revealed in protein kinase C
mutant mice.
Neuron
24:253-260[Web of Science][Medline]. -
LaMotte RM,
Thalhamme JG,
Robinson CJ
(1983)
Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: a comparison of neural events in monkey with sensory judgments in human.
J Neurophysiol
50:1-26[Free Full Text].
-
Martin KC,
Michael D,
Rose JC,
Barad M,
Casadio A,
Zhu H,
Kandel ER
(1997)
MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia.
Neuron
18:899-912[Web of Science][Medline].
-
Michael GJ,
Averill S,
Nitkunan A,
Rattray M,
Bennett DL,
Yan Q,
Priestley JV
(1997)
Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord.
J Neurosci
17:8476-8490[Abstract/Free Full Text].
-
Noguchi K,
Kawai Y,
Fukuoka T,
Senba E,
Miki K
(1995)
Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons.
J Neurosci
15:7633-7643[Abstract].
-
Obrietan K,
Impey S,
Storm DR
(1998)
Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei.
Nat Neurosci
1:693-700[Web of Science][Medline].
-
Premkumar LS,
Ahern GP
(2000)
Induction of vanilloid receptor channel activity by protein kinase C.
Nature
408:985-990[Medline].
-
Raja SN,
Meyer RA,
Ringkamp M,
Campbell JN
(1999)
Peripheral neural mechanisms of nociception.
In: Textbook of pain (Wall PD,
Melzack R,
eds), pp 11-57. New York: Churchill Livingstone.
-
Rosen LB,
Ginty DD,
Weber MJ,
Greenberg ME
(1994)
Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras.
Neuron
12:1207-1221[Web of Science][Medline].
-
Shindler KS,
Roth KA
(1996)
Double immunofluorescent staining using two unconjugated primary antisera raised in the same species.
J Histochem Cytochem
44:1331-1335[Abstract].
-
Snider WD,
McMahon SB
(1998)
Tackling pain at the source: new ideas about nociceptors.
Neuron
20:629-632[Web of Science][Medline].
-
Tominaga M,
Caterina MJ,
Malmberg AB,
Rosen TA,
Gilbert H,
Skinner K,
Raumann BE,
Basbaum AI,
Julius D
(1998)
The cloned capsaicin receptor integrates multiple pain-producing stimuli.
Neuron
21:531-543[Web of Science][Medline].
-
Torebjork HE,
Lundberg LER,
LaMotte RH
(1992)
Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans.
J Neurophysiol
448:765-780.
-
Trojanowski JQ,
Walkenstein N,
Lee VM
(1986)
Expression of neurofilament subunits in neurons of the central and peripheral nervous system: an immunohistochemical study with monoclonal antibodies.
J Neurosci
6:650-660[Abstract].
-
Willis WD,
Coggeshall RE
(1991)
Peripheral nerves and sensory receptors.
In: Sensory mechanisms of the spinal cord, Ed 2, pp 13-45 Plenum, New York.
-
Woolf CJ,
Salter MW
(2000)
Neuronal plasticity: increasing the gain in pain.
Science
288:1765-1769[Abstract/Free Full Text].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22177737-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M.-L. Sixt, K. Messlinger, and M. J. M. Fischer
Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus
Brain,
November 1, 2009;
132(11):
3134 - 3141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Peng, M. Han, Y. Du, A. Lin, L. Yu, Y. Zhang, and N. Jing
SIP30 Is Regulated by ERK in Peripheral Nerve Injury-induced Neuropathic Pain
J. Biol. Chem.,
October 30, 2009;
284(44):
30138 - 30147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Kondo, K Obata, K Miyoshi, J Sakurai, J Tanaka, H Miwa, and K Noguchi
Transient receptor potential A1 mediates gastric distention-induced visceral pain in rats
Gut,
October 1, 2009;
58(10):
1342 - 1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fukuda, S. Hisano, and M. Tanaka
Licking Decreases Phosphorylation of Extracellular Signal-Regulated Kinase in the Dorsal Horn of the Spinal Cord After a Formalin Test
Anesth. Analg.,
October 1, 2009;
109(4):
1318 - 1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Matsunami, T Tarui, K Mitani, K Nagasawa, O Fukushima, K Okubo, S Yoshida, M Takemura, and A Kawabata
Luminal hydrogen sulfide plays a pronociceptive role in mouse colon
Gut,
June 1, 2009;
58(6):
751 - 761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Korkmaz, W. Bloch, K. Schneider, S. Zimmer, K. Addicks, and W.H.-M. Raab
Time-dependent Activation of ERK1/2 in Nerve Terminals of the Dentin-Pulp Complex following Bradykinin Treatment
Journal of Dental Research,
December 1, 2008;
87(12):
1149 - 1154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Niinomi, Y. Banno, H. Iida, and S. Dohi
Nicorandil, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Inhibits Muscarinic Acetylcholine Receptor-Mediated Activation of Extracellular Signal-Regulated Kinases in PC12 Cells
Anesth. Analg.,
December 1, 2008;
107(6):
1892 - 1898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-Y. Ho, P.-J. Lu, M. Hsiao, H.-R. Hwang, Y.-C. Tseng, M.-H. Yen, and C.-J. Tseng
Adenosine Modulates Cardiovascular Functions Through Activation of Extracellular Signal-Regulated Kinases 1 and 2 and Endothelial Nitric Oxide Synthase in the Nucleus Tractus Solitarii of Rats
Circulation,
February 12, 2008;
117(6):
773 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Garraway, Q. Xu, and C. E. Inturrisi
Design and Evaluation of Small Interfering RNAs That Target Expression of the N-Methyl-D-aspartate Receptor NR1 Subunit Gene in the Spinal Cord Dorsal Horn
J. Pharmacol. Exp. Ther.,
September 1, 2007;
322(3):
982 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rozenfeld and L. A. Devi
Receptor heterodimerization leads to a switch in signaling: {beta}-arrestin2-mediated ERK activation by {micro}-{delta} opioid receptor heterodimers
FASEB J,
August 1, 2007;
21(10):
2455 - 2465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Gillis, D. A. Martyn, A. J. Rivera, and M. Regnier
Investigation of thin filament near-neighbour regulatory unit interactions during force development in skinned cardiac and skeleta muscle
J. Physiol.,
April 15, 2007;
580(2):
561 - 576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mizushima, K. Obata, H. Katsura, J. Sakurai, K. Kobayashi, H. Yamanaka, Y. Dai, T. Fukuoka, T. Mashimo, and K. Noguchi
Intensity-Dependent Activation of Extracellular Signal-Regulated Protein Kinase 5 in Sensory Neurons Contributes to Pain Hypersensitivity
J. Pharmacol. Exp. Ther.,
April 1, 2007;
321(1):
28 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-Y. Qiao and M. A. Gulick
Region-specific changes in the phosphorylation of ERK1/2 and ERK5 in rat micturition pathways following cyclophosphamide-induced cystitis
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2007;
292(3):
R1368 - R1375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Nicol and M. R. Vasko
Unraveling the Story of NGF-mediated Sensitization of Nociceptive Sensory Neurons: ON or OFF the Trks?
Mol. Interv.,
February 1, 2007;
7(1):
26 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Zhang, J. C. Fehrenbacher, M. R. Vasko, and G. D. Nicol
Sphingosine-1-Phosphate Via Activation of a G-Protein-Coupled Receptor(s) Enhances the Excitability of Rat Sensory Neurons
J Neurophysiol,
September 1, 2006;
96(3):
1042 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Obata, H. Yamanaka, K. Kobayashi, Y. Dai, T. Mizushima, H. Katsura, T. Fukuoka, A. Tokunaga, and K. Noguchi
Role of Mitogen-Activated Protein Kinase Activation in Injured and Intact Primary Afferent Neurons for Mechanical and Heat Hypersensitivity after Spinal Nerve Ligation
J. Neurosci.,
November 10, 2004;
24(45):
10211 - 10222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, A. N. Sinoway, Z. Gao, M. D. Maile, M. Pu, and L. I. Sinoway
Muscle Mechanoreflex and Metaboreflex Responses After Myocardial Infarction in Rats
Circulation,
November 9, 2004;
110(19):
3049 - 3054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal.,
September 28, 2004;
2004(252):
re14 - re14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Y. Zhuang, H. Xu, D. E. Clapham, and R.-R. Ji
Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization
J. Neurosci.,
September 22, 2004;
24(38):
8300 - 8309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dai, T. Moriyama, T. Higashi, K. Togashi, K. Kobayashi, H. Yamanaka, M. Tominaga, and K. Noguchi
Proteinase-Activated Receptor 2-Mediated Potentiation of Transient Receptor Potential Vanilloid Subfamily 1 Activity Reveals a Mechanism for Proteinase-Induced Inflammatory Pain
J. Neurosci.,
May 5, 2004;
24(18):
4293 - 4299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Rashid, M. Inoue, M. Matsumoto, and H. Ueda
Switching of Bradykinin-Mediated Nociception Following Partial Sciatic Nerve Injury in Mice
J. Pharmacol. Exp. Ther.,
March 1, 2004;
308(3):
1158 - 1164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S B McMahon
Sensitisation of gastrointestinal tract afferents
Gut,
March 1, 2004;
53(90002):
ii13 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Jordan, I. Gomes, C Rios, J. Filipovska, and L. A. Devi
Functional Interactions between {micro} Opioid and {alpha}2A-Adrenergic Receptors
Mol. Pharmacol.,
December 1, 2003;
64(6):
1317 - 1324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Abbadie, J. A. Lindia, A. M. Cumiskey, L. B. Peterson, J. S. Mudgett, E. K. Bayne, J. A. DeMartino, D. E. MacIntyre, and M. J. Forrest
Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
PNAS,
June 24, 2003;
100(13):
7947 - 7952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-X. Jin, Z.-Y. Zhuang, C. J. Woolf, and R.-R. Ji
p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain
J. Neurosci.,
May 15, 2003;
23(10):
4017 - 4022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Obata, H. Yamanaka, Y. Dai, T. Tachibana, T. Fukuoka, A. Tokunaga, H. Yoshikawa, and K. Noguchi
Differential Activation of Extracellular Signal-Regulated Protein Kinase in Primary Afferent Neurons Regulates Brain-Derived Neurotrophic Factor Expression after Peripheral Inflammation and Nerve Injury
J. Neurosci.,
May 15, 2003;
23(10):
4117 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|